FDA NCTR Building 62 Motor Control Center Switchgear Replacement

This is a Sources Sought Notice (SSN) - a market survey designed to collect written information only.

This is not a solicitation announcement for proposals and no contract will be awarded from this announcement. No reimbursement will be made for any costs associated with providing information in response to this announcement or any follow-up information requests. There is no RFQ, or other iteration of a solicitation associated with this Notice, and no telephone calls will be accepted requesting an RFQ package or solicitation. To protect the procurement integrity of any future acquisition that may arise from this announcement, information regarding a government technical

point of contact will not be given and no appointments for presentations will be made. The U.S. Food and Drug Administration (FDA), (OAGS) issues this Sources Sought Notice (SSN) on behalf of the National Center for Toxicological Research (NCTR), to determine the presence of small business sources capable of completing a project to replace existing motor control centers (MCC’s), switchgear equipment, and draw-out breakers in Bldg. 62 of the FDA facility in Jefferson, Arkansas. Many of the current MCC’s in this building are original and date back to the 1940’s and 1950’s. Breakers in switchgear will be replaced with new ones and tested as shown in the construction documents attached to this Notice. Arc-flash studies and thermal scanning will also be conducted on all replaced MCC's draw-out breakers. If your firm is actively registered in SAM as a small business source under North American Industry System (NAICS) code 238210 (Electrical Contractors and Other Wiring Installation Contractors), with a size standard of $19.0 million, and you believe that your firm would be able to provide the FDA with the commercial construction services described below, please submit an email containing a capability statement to [email protected] by the date and time specified on the last page of this Notice. Other than small business concerns are also encouraged to submit capability statements.

Period of Performance Estimated

period of performance is 24 months after official Notice to Proceed.

Place of Performance The equipment is located at the National Center for Toxicological Research (NCTR) at the following address: U.S. Food and Drug Administration (FDA) National Center for Toxicological Research (NCTR) 3900 NCTR Rd., Bldg. 62 Jefferson AR 72079 Responses to this Sources Sought shall unequivocally demonstrate that the respondent is regularly engaged in the performance of the services required herein. Though the target audience is small business vendors or small businesses capable of supplying a U.S. product/service of a small business vendor or producer, all interested parties may respond in the form of a capabilities statement. At a minimum, capability statements shall include the following: Business name and bio, Unique Entity ID (SAM) number, business address, business website, business size status (i.e., SB, VOSB, SDVOSB, HUBZone SB, SDB, WOSB, LB),